Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Immutep Ltd (PRRUF)
OTHER OTC:PRRUF
Holding PRRUF?
Track your performance easily
PRRUF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.13 - $0.38
Previous Close$0.23
Volume3.00
Average Volume (3M)5.37K
Market Cap
$334.26M
Enterprise Value$252.30M
Total Cash (Recent Filing)AU$123.42M
Total Debt (Recent Filing)AU$1.23M
Price to Earnings (P/E)―
Beta0.66
Next Earnings
Feb 20, 2025EPS Estimate
-$0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding879,089,453
10 Day Avg. Volume0
30 Day Avg. Volume5,371
Standard Deviation0.34
R-Squared0.00139
Alpha0.05
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)209.01
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$0.64Price Target Upside182.06% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Immutep Ltd News
PremiumCompany Announcements
Immutep Director Increases Shareholding
PremiumCompany Announcements
Immutep’s Efti Shows Promise in Head and Neck Cancer
PremiumCompany Announcements
JPMorgan Acquires Substantial Stake in Immutep Ltd
PremiumCompany Announcements
Immutep Limited Faces Higher Annual LossPremiumCompany Announcements
Immutep Ltd Updates on Immune-Oncology ProgressOwnership Overview
5.60% Insiders
0.02% Mutual Funds
0.10% Other Institutional Investors
94.28% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
PRRUF FAQ
What was Immutep Ltd’s price range in the past 12 months?
Immutep Ltd lowest stock price was $0.13 and its highest was $0.38 in the past 12 months.
What is Immutep Ltd’s market cap?
Currently, no data Available
When is Immutep Ltd’s upcoming earnings report date?
Immutep Ltd’s upcoming earnings report date is Feb 20, 2025 which is in 153 days.
How were Immutep Ltd’s earnings last quarter?
Immutep Ltd released its earnings results on Aug 28, 2024. The company reported -$0.012 earnings per share for the quarter, beating the consensus estimate of -$0.013 by <$0.001.
Is Immutep Ltd overvalued?
According to Wall Street analysts Immutep Ltd’s price is currently Undervalued.
Does Immutep Ltd pay dividends?
Immutep Ltd does not currently pay dividends.
What is Immutep Ltd’s EPS estimate?
Immutep Ltd’s EPS estimate is -$0.01.
How many shares outstanding does Immutep Ltd have?
Immutep Ltd has 1,452,612,300 shares outstanding.
What happened to Immutep Ltd’s price movement after its last earnings report?
Immutep Ltd reported an EPS of -$0.012 in its last earnings report, beating expectations of -$0.013. Following the earnings report the stock price went up 4%.
Which hedge fund is a major shareholder of Immutep Ltd?
Currently, no hedge funds are holding shares in PRRUF
---
Immutep Ltd Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$0.64 (182.06% Upside)
$0.64 (182.06% Upside)
Blogger Sentiment
Bullish
PRRUF Sentiment 97%
Sector Average 71%
Sector Average 71%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
20.20%
12-Months-Change
Fundamentals
Return on Equity
-25.75%
Trailing 12-Months
Asset Growth
37.16%
Trailing 12-Months
Company Description
Immutep Ltd
Immutep Ltd. is a biotechnology company, which engages in the research and development of immunotherapeutic treatments for cancer and autoimmune diseases. Its product is IMP321, which involves in clinical development for the treatment of breast cancer and melanoma. The company was founded on May 21, 1987 and is headquartered in Sydney, Australia.
---
PRRUF Stock 12 Month Forecast
Average Price Target
$0.64
▲(182.06% Upside)
Technical Analysis
Best Analysts Covering PRRUF
1 Year
1 Year Success Rate
6/14 ratings generated profit
1 Year Average Return
+3.23%
reiterated a buy rating 11 days ago
Copying Melissa Benson's trades and holding each position for 1 Year would result in 42.86% of your transactions generating a profit, with an average return of +3.23% per trade.
---